The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment

被引：0
|
作者：
Jin, Feng [1 ]
Robeson, Michelle [2 ]
Zhou, Huafeng [2 ]
Hisoire, Grace [1 ]
Ramanathan, Srini [1 ]
机构：
[1] Gilead Sci Inc, Foster City, CA 94404 USA
[2] Gilead Sci Inc, Seattle, WA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-CT204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT204
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
    Min, K. Chris
    Lasseter, Kenneth C.
    Marbury, Thomas C.
    Wrishko, Rebecca E.
    Hanley, William D.
    Wolford, Dennis G.
    de Haes, Joanna Udo
    Reitmann, Christina
    Gutstein, David E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (09) : 746 - 752
  • [12] Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment
    Custodio, Joseph M.
    Fordyce, Marshall
    Garner, William
    Vimal, Mona
    Ling, Kah Hiing J.
    Kearney, Brian P.
    Ramanathan, Srinivasan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (09) : 5135 - 5140
  • [13] Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment
    Xin, Yan
    Kawashima, Jun
    Weng, Winnie
    Kwan, Ellen
    Tarnowski, Thomas
    Silverman, Jeffrey A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (04): : 522 - 532
  • [14] The pharmacokinetics and safety of desvenlafaxine in subjects with chronic renal impairment
    Nichols, A. I.
    Richards, L. S.
    Behrle, J. A.
    Posener, J. A.
    McGrory, S. B.
    Paul, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (01) : 3 - 13
  • [15] Pharmacokinetics and pharmacodynamics of tonapofylline in subjects with severe renal impairment and in elderly subjects
    Li, Z.
    TenHoor, C.
    Marbury, T.
    Swan, S.
    Zhu, Y.
    Ticho, B.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (09) : 563 - 570
  • [16] PHARMACOKINETICS AND SAFETY OF TENOFOVIR ALAFENAMIDE IN SUBJECTS WITH SEVERE HEPATIC IMPAIRMENT
    Custodio, J. M.
    Ma, G.
    Cuvin, J.
    Ting, L.
    Flaherty, J.
    Zack, J. Z.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S594 - S595
  • [17] Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
    Charlotte Granhall
    Flemming L. Søndergaard
    Mette Thomsen
    Thomas W. Anderson
    Clinical Pharmacokinetics, 2018, 57 : 1571 - 1580
  • [18] Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
    Granhall, Charlotte
    Sondergaard, Flemming L.
    Thomsen, Mette
    Anderson, Thomas W.
    CLINICAL PHARMACOKINETICS, 2018, 57 (12) : 1571 - 1580
  • [19] Pharmacokinetics and Safety of Ebastine in Healthy Subjects and Patients with Renal Impairment
    Robert J. Noveck
    Richard A. Preston
    Suzanne K. Swan
    Clinical Pharmacokinetics, 2007, 46 : 525 - 534
  • [20] Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment
    Noveck, Robert J.
    Preston, Richard A.
    Swan, Suzanne K.
    CLINICAL PHARMACOKINETICS, 2007, 46 (06) : 525 - 534
12345